Revenue: The sum of all revenue fields included for a company's operating activities.
Neurogene Inc. (NGNE) Revenue data is not available for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
-- |
$-22.65M |
|
-- |
|
-- |
|
$25.92M |
|
$-25.92M |
|
$3.27M |
|
$-22.65M |
|
$-22.65M |
|
$-22.65M |
|
$-22.65M |
|
$-22.65M |
|
$-22.65M |
|
$-25.92M |
|
$-26.90M |
|
21.00M |
|
21.00M |
|
$-1.08 |
|
$-1.08 |
|
| Balance Sheet Financials | |
$296.40M |
|
$14.81M |
|
$18.90M |
|
$315.30M |
|
$14.09M |
|
$0.02M |
|
$9.41M |
|
$23.51M |
|
$291.80M |
|
$291.80M |
|
$291.80M |
|
14.93M |
|
| Cash Flow Statement Financials | |
$-20.77M |
|
$-45.05M |
|
$0.00M |
|
$136.93M |
|
$71.11M |
|
$-65.81M |
|
$4.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
21.03 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-21.55M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-7.76% |
|
-7.76% |
|
-7.18% |
|
-7.76% |
|
$19.54 |
|
$-1.03 |
|
$-0.99 |
|